🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT05538871
Recruiting Observational

Body Structure and Capacity Evaluation of Adults With Scoliosis

NCT05538871 · tracked via the Priya Life Science Canada tracker
Phase
Observational
Started
2019-05-06
Last updated
2026-06-25

Condition(s) studied

Scoliosis

Investigational drug(s) / intervention(s)

Survey + Physical exam

Survey + Physical exam: Survey: Demographic data Pain Oswestry disability index International Physical Activity Questionnaire Scoliosis Research Society (SRS-22r) Spinal appearance questionnaire Fear Avoidance and Beliefs Questionnaire Short Orebro musculoskeletal pain questionnaire Work Ability Index Physical exam: Repeated movements (MDT) Posture ROM Neuro Updated treatment based classification tests Pathoanatomical classification tests

Study summary

Adults with scoliosis have not been the focus of much research in physical therapy despite their prevalence being very important. Adults with idiopathic scoliosis have a reported prevalence of about 2-11%. This includes adolescents with idiopathic scoliosis who have become adults but still have a scoliosis. They do not get much treatment as the adolescent treatment focuses on preventing worsening of the curvatures and the risk of progression is significantly reduced once a person reaches skeletal maturity. Still some patients experience self-image, function and pain issues which may be amenable to treatment using specific exercises as was recently shown. With ageing population a growing number of adults with de novo degenerative scoliosis is observed. This is a spinal misalignment due to spine degeneration. Adult degenerative scoliosis with pain is thought to affect about 24% of the ageing adults. This population has not been investigated very much.

Before planning conservative treatments for adults with scoliosis it would be important to describe what deficit these adults present that may be targeted by physical therapy. The objective of this study is to compare samples of patients with adults degenerative scoliosis, adult idiopathic scoliosis to matched healthy controls (for age, height and weight). Participants will complete questionnaires and a physical exam to identify which limitations they present that may be amenable to treatment with physical therapy. This information will assist planning trials to address the needs of these two neglected patient populations.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion criteria for the idiopathic scoliosis group : * Diagnosis of idiopathic scoliosis * Age ⩾18 years old * Curve severity over 10° * Fluent in English. Inclusion criteria for the degenerative scoliosis group : * Diagnosis of degenerative (De novo) scoliosis * Age ⩾45 years old * Curve severity over 10° * Fluent in English. Exclusion criteria for the scoliosis groups : * History of spine surgery or * History of diseases affecting the torso or lower extremity function * Surgery or trauma * Secondary scoliosis * Unable to fill out the questionnaires or attend the physical examination, * Pregnant or gave birth between 0 and 2 years ago. Inclusion criteria for healthy groups: * Age ⩾ 18 years * Matched for age/height/weight (+/-5 years; +/- 10 lbs; +/- 10cm) to a scoliosis participant * Fluent in English Exclusion criteria for healthy groups: * Serious systemic pathology * Spine deformity * Spine surgery * Pregnant or gave birth between 0 and 2 years ago * Unable to fill out the questionnaires or attend the physical examination * Received treatments for the spine/the lower limbs within the last year

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University of Alberta, Faculty of Rehabilitation Medicine, Dept. Physical Therapy Edmonton Alberta Recruiting

More University of Alberta trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05538871 on ClinicalTrials.gov ↗ ← All trials in Canada